Phase II study of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial carcinoma (UC): Analysis of the second cohort of CALGB 90102.
Philips, G; Sanford, B; Halabi, S; Bajorin, D; Small, EJ
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
42nd Annual Meeting of the American-Society-of-Clinical-Oncology
Conference Start Date
Conference End Date